Javascript must be enabled to continue!
Essential Role of Gab1 for Signaling by the C-Met Receptor in Vivo
View through CrossRef
The docking protein Gab1 binds phosphorylated c-Met receptor tyrosine kinase directly and mediates signals of c-Met in cell culture. Gab1 is phosphorylated by c-Met and by other receptor and nonreceptor tyrosine kinases. Here, we report the functional analysis of Gab1 by targeted mutagenesis in the mouse, and compare the phenotypes of the Gab1 and c-Met mutations. Gab1 is essential for several steps in development: migration of myogenic precursor cells into the limb anlage is impaired in Gab1−/− embryos. As a consequence, extensor muscle groups of the forelimbs are virtually absent, and the flexor muscles reach less far. Fewer hindlimb muscles exist, which are smaller and disorganized. Muscles in the diaphragm, which also originate from migratory precursors, are missing. Moreover, Gab1−/− embryos die in a broad time window between E13.5 and E18.5, and display reduced liver size and placental defects. The labyrinth layer, but not the spongiotrophoblast layer, of the placenta is severely reduced, resulting in impaired communication between maternal and fetal circulation. Thus, extensive similarities between the phenotypes of c-Met and HGF/SF mutant mice exist, and the muscle migration phenotype is even more pronounced in Gab1−/−:c-Met+/− embryos. This is genetic evidence that Gab1 is essential for c-Met signaling in vivo. Analogy exists to signal transmission by insulin receptors, which require IRS1 and IRS2 as specific docking proteins.
Title: Essential Role of Gab1 for Signaling by the C-Met Receptor in Vivo
Description:
The docking protein Gab1 binds phosphorylated c-Met receptor tyrosine kinase directly and mediates signals of c-Met in cell culture.
Gab1 is phosphorylated by c-Met and by other receptor and nonreceptor tyrosine kinases.
Here, we report the functional analysis of Gab1 by targeted mutagenesis in the mouse, and compare the phenotypes of the Gab1 and c-Met mutations.
Gab1 is essential for several steps in development: migration of myogenic precursor cells into the limb anlage is impaired in Gab1−/− embryos.
As a consequence, extensor muscle groups of the forelimbs are virtually absent, and the flexor muscles reach less far.
Fewer hindlimb muscles exist, which are smaller and disorganized.
Muscles in the diaphragm, which also originate from migratory precursors, are missing.
Moreover, Gab1−/− embryos die in a broad time window between E13.
5 and E18.
5, and display reduced liver size and placental defects.
The labyrinth layer, but not the spongiotrophoblast layer, of the placenta is severely reduced, resulting in impaired communication between maternal and fetal circulation.
Thus, extensive similarities between the phenotypes of c-Met and HGF/SF mutant mice exist, and the muscle migration phenotype is even more pronounced in Gab1−/−:c-Met+/− embryos.
This is genetic evidence that Gab1 is essential for c-Met signaling in vivo.
Analogy exists to signal transmission by insulin receptors, which require IRS1 and IRS2 as specific docking proteins.
Related Results
miR-153-5p suppresses the proliferation, invasion and migration of malignant meningioma via the MEK/ERK signaling pathway by targeting GAB1
miR-153-5p suppresses the proliferation, invasion and migration of malignant meningioma via the MEK/ERK signaling pathway by targeting GAB1
Abstract
Aims:This study aimed to determine the role and correlation of miR-153-5p and GAB1 in the proliferation, invasion and migration of malignant meningioma.
Background...
Role of GRB2‐associated binder 1 in epidermal growth factor receptor‐induced signaling in head and neck squamous cell carcinoma
Role of GRB2‐associated binder 1 in epidermal growth factor receptor‐induced signaling in head and neck squamous cell carcinoma
AbstractThe epidermal growth factor receptor (EGFR) plays an important role in the pathogenesis of head and neck squamous cell carcinoma (HNSCC). Despite the high expression of EGF...
miR-3606-3p alleviates skin fibrosis by suppressing fibroblast inflammation and migration via inhibiting GAB1 and ITGAV
miR-3606-3p alleviates skin fibrosis by suppressing fibroblast inflammation and migration via inhibiting GAB1 and ITGAV
Abstract
Systemic sclerosis (SSc) and keloid are typical skin fibrotic diseases with unclear epigenetic mechanisms and clinical targets, this study aimed to assess the role...
Cometary Physics Laboratory: spectrophotometric experiments
Cometary Physics Laboratory: spectrophotometric experiments
<p><strong><span dir="ltr" role="presentation">1. Introduction</span></strong&...
Identification of microRNA-Regulated Pathways through a Integration of Mcrorna-mRNA Microarray and Bioinformatics Analysis in CD34+ Cells of Myelodysplastic Syndromes
Identification of microRNA-Regulated Pathways through a Integration of Mcrorna-mRNA Microarray and Bioinformatics Analysis in CD34+ Cells of Myelodysplastic Syndromes
Abstract
Background
MicroRNAs (miRNAs) are considered to play a key role in the pathogenesis of myelodysplastic syndromes (MDS). However, the effect o...
Abstract B26: PI3K class I and mTOR regulate distinct steps in Met dependent tumorigenesis
Abstract B26: PI3K class I and mTOR regulate distinct steps in Met dependent tumorigenesis
Abstract
The Receptor Tyrosine Kinase (RTK) Met, overexpressed or mutated in cancer, plays a major role in cancer progression and represents an attractive target for...
Mutations in Insulin-Receptor Gene in Insulin-Resistant Patients
Mutations in Insulin-Receptor Gene in Insulin-Resistant Patients
Defects in insulin-receptor function have been associated with insulin-resistant states such as obesity and non-insulin-dependent diabetes mellitus (NIDDM). Several types of mutati...
MET
Dependence Oversteps
EGFR
Dependence via Balancing Dimerization of the Receptor Tyrosine Kinases in Osimertinib‐Resistant
MET
‐Amplified,
MET
Dependence Oversteps
EGFR
Dependence via Balancing Dimerization of the Receptor Tyrosine Kinases in Osimertinib‐Resistant
MET
‐Amplified,
ABSTRACT
Background
Although epidermal growth factor receptor tyrosine kinase inhibitors (EGFR‐TKI...

